China Shineway Pharmaceutical Group Limited
CSWYY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $260,405 | $255,414 | $303,757 | $253,116 |
| - Cash | $6,860,819 | $6,140,153 | $6,234,974 | $5,888,776 |
| + Debt | $341,336 | $346,527 | $351,056 | $301,326 |
| Enterprise Value | -$6,259,078 | -$5,538,212 | -$5,580,161 | -$5,334,334 |
| Revenue | $227,809 | $235,618 | – | $2,117,858 |
| % Growth | -3.3% | – | – | – |
| Gross Profit | $164,528 | $175,467 | – | $1,590,162 |
| % Margin | 72.2% | 74.5% | – | 75.1% |
| EBITDA | $117,782 | $50,210 | – | $463,874 |
| % Margin | 51.7% | 21.3% | – | 21.9% |
| Net Income | $84,726 | $29,752 | – | $478,045 |
| % Margin | 37.2% | 12.6% | – | 22.6% |
| EPS Diluted | 44.8 | 15.8 | – | 253.2 |
| % Growth | 183.5% | – | – | – |
| Operating Cash Flow | $95,285 | $62,234 | – | $611,254 |
| Capital Expenditures | -$13,869 | -$9,194 | – | -$95,176 |
| Free Cash Flow | $81,416 | $53,040 | – | $516,078 |